| NCT Number | NCT06326567 |
| Lead Sponsor | Timothy Mullett
Collaborators: Merck Sharp & Dohme LLC |
| Conditions | Cancer, Health Care Utilization |
| Enrollment | 300 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2027-06 (estimated) |
| Study Completion | 2027-12 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-22 |